{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:16Z","timestamp":1791228616789,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008238","name":"Hebei Province Department of Science And Technology","doi-asserted-by":"publisher","award":["223777114D"],"award-info":[{"award-number":["223777114D"]}],"id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["H2020206554"],"award-info":[{"award-number":["H2020206554"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.toxlet.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T15:27:05Z","timestamp":1715268425000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Transcriptomics coupled with proteomics reveals osimertinib-induced myocardial mitochondrial dysfunction"],"prefix":"10.1016","volume":"397","author":[{"given":"Haichao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiezhu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2024.05.005_bib1","article-title":"Mitochondrial dynamics imbalance and mitochondrial dysfunction contribute to the molecular cardiotoxic effects of Lenvatinib","volume":"423","author":"Akyildiz","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.toxlet.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaccao.2019.10.006","article-title":"Osimertinib-induced cardiotoxicity: a retrospective review of the FDA Adverse Events Reporting System (FAERS)","volume":"1","author":"Anand","year":"2019","journal-title":"Jacc. CardioOncol."},{"issue":"4","key":"10.1016\/j.toxlet.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/10781552211073823","article-title":"Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma","volume":"28","author":"Bardaro","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"11","key":"10.1016\/j.toxlet.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3390\/antiox12111941","article-title":"Status of mitochondrial oxidative phosphorylation during the development of heart failure","volume":"12","author":"Bhullar","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.toxlet.2024.05.005_bib5","doi-asserted-by":"crossref","unstructured":"Bouitbir, J., Alshaikhalo, A., Panajatovic, M.V., et al., 2019. Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib: Running title: Sunitinib and oxidative stress in hearts. 426, 152281. \u3008https:\/\/doi.org\/10.1016\/j.tox.2019.152281\u3009.","DOI":"10.1016\/j.tox.2019.152281"},{"issue":"4","key":"10.1016\/j.toxlet.2024.05.005_bib6","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.3390\/ijms23042282","article-title":"Mitochondrial toxicity associated with imatinib and sorafenib in isolated rat heart fibers and the cardiomyoblast H9c2 cell line","volume":"23","author":"Bouitbir","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2024.05.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2023.2294924","article-title":"Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer","volume":"13","author":"Byun","year":"2023","journal-title":"Expert. Opin. Drug. Saf."},{"issue":"9","key":"10.1016\/j.toxlet.2024.05.005_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.toxlet.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2022.06.001","article-title":"Downregulation of hERG channel expression by tyrosine kinase inhibitors nilotinib and vandetanib predominantly contributes to arrhythmogenesis","volume":"365","author":"Cui","year":"2022","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.toxlet.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1200\/JCO.20.01171","article-title":"Cardiac safety of osimertinib: a review of data","volume":"39","author":"Ewer","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.toxlet.2024.05.005_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd3252","article-title":"Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes","volume":"10","author":"Force","year":"2011","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/j.toxlet.2024.05.005_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/medicina58020312","article-title":"Successful management of osimertinib-induced heart failure","volume":"58","author":"Fukuo","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.toxlet.2024.05.005_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CCO.0000000000000696","article-title":"Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer","volume":"33","author":"Gong","year":"2021","journal-title":"Curr. Opin. Oncol."},{"issue":"3","key":"10.1016\/j.toxlet.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/10781552221077417","article-title":"Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?","volume":"29","author":"Kobat","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.toxlet.2024.05.005_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.lungcan.2020.10.021","article-title":"Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction","volume":"153","author":"Kunimasa","year":"2021","journal-title":"Lung. Cancer"},{"key":"10.1016\/j.toxlet.2024.05.005_bib16","article-title":"Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.05.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153348","article-title":"Impaired autophagy and mitochondrial dynamics are involved in Sorafenib-induced cardiomyocyte apoptosis","volume":"481","author":"Liang","year":"2022","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.toxlet.2024.05.005_bib18","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1158\/1078-0432.CCR-17-1875","article-title":"Targeting HER2 aberrations in non-small cell lung cancer with osimertinib","volume":"24","author":"Liu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.toxlet.2024.05.005_bib19","first-page":"19","article-title":"Regulation of mitochondrial ATP synthase in cardiac pathophysiology","volume":"5","author":"Long","year":"2015","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"9","key":"10.1016\/j.toxlet.2024.05.005_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.26599\/1671-5411.2023.09.006","article-title":"Osimertinib induced adverse cardiac events: a case report","volume":"20","author":"Lu","year":"2023","journal-title":"J. Geriatr. Cardiol."},{"issue":"1","key":"10.1016\/j.toxlet.2024.05.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/bmc-2019-0001","article-title":"ATP synthase: structure, function and inhibition","volume":"10","author":"Neupane","year":"2019","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.toxlet.2024.05.005_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol."},{"issue":"A)","key":"10.1016\/j.toxlet.2024.05.005_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2015.04.056","article-title":"Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease","volume":"763","author":"Ong","year":"2015","journal-title":"Eur. J. Pharmcol."},{"key":"10.1016\/j.toxlet.2024.05.005_bib24","article-title":"Emerging treatment paradigms for EGFR-mutant lung cancers progressing on osimertinib: a review","volume":"18","author":"Piper-Vallillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.toxlet.2024.05.005_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvn184","article-title":"Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation","volume":"80","author":"Rosca","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.toxlet.2024.05.005_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","article-title":"A historical overview of protein kinases and their targeted small molecule inhibitors","volume":"100","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.toxlet.2024.05.005_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/10781552221143787","article-title":"Possible heart failure caused by osimertinib in a lung cancer patient","volume":"29","author":"Ruiz-Briones","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"3","key":"10.1016\/j.toxlet.2024.05.005_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.hfc.2022.02.003","article-title":"Intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity","volume":"18","author":"Scott","year":"2022","journal-title":"Heart Fail. Clin."},{"issue":"377","key":"10.1016\/j.toxlet.2024.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.toxlet.2024.05.005_bib30","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/jcp.27597","article-title":"Mitochondrial quality control in cardiac cells: mechanisms and role in cardiac cell injury and disease","volume":"234","author":"Tahrir","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.toxlet.2024.05.005_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-255245","article-title":"Severe cardiotoxicity induced by osimertinib in a patient with EGFR-mutated adenocarcinoma of the lung","volume":"16","author":"Tanaka","year":"2023","journal-title":"Bmj. Case. Rep."},{"key":"10.1016\/j.toxlet.2024.05.005_bib32","unstructured":"U.S. FDA, CDER, 2015. Highlights of Prescribing Information. U.S. FDA. \u3008www.fda.gov\/medwatch\u3009 (accessed 24 December 2020)."},{"key":"10.1016\/j.toxlet.2024.05.005_bib33","article-title":"Aumolertinib effectively reduces clinical symptoms of an EGFR L858R-mutant non-small cell lung cancer case coupled with osimertinib-induced cardiotoxicity: case report and review","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"1","key":"10.1016\/j.toxlet.2024.05.005_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcb.27434","article-title":"AZD9291 promotes autophagy and inhibits PI3K\/Akt pathway in NSCLC cancer cells","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:04:45Z","timestamp":1718244285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427424000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S0378427424000924"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.05.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomics coupled with proteomics reveals osimertinib-induced myocardial mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}